Discovery of Antivirulence ClpP Inhibitors by Self‐Resistance Gene‐Guided Mining Coupled with Dual Functional Screening
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202514683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Yongchao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, School of Ph…. Hauptthemen laut MEDLINE: Endopeptidase Clp, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Wuhan University.
Abstract (Originalsprache)
The global threat of MRSA demands innovative anti‐virulence strategies. Caseinolytic peptidase P (ClpP), a central virulence regulator in MRSA, represents an attractive yet underexploited target. Here, we developed a discovery platform integrating self‐resistance gene‐guided genome mining with dual functional screening, combining fluorometric‐based assay and counter‐screening against ADEP‐induced ClpP activation. This led to the discovery of streptoclipamides A–G, novel hybrid polyketide‐nonribosomal peptide ClpP inhibitors from str BGC, validated via heterologous expression and gene knockout. Structure–activity relationship studies enabled by engineered analogues identified key pharmacophores. Streptoclipamide A potently inhibits ClpP (IC 50 = 480 nM) by engaging Thr72 via its C‐21 hydroxyl group, confirmed by biophysics and self‐resistance‐conferring T72P mutation. Streptoclipamide A suppressed MRSA virulence in vitro by reducing critical toxin production, including α‐hemolysin, and demonstrated protection in Galleria mellonella and murine pneumonia models. This work expands chemical diversity of ClpP‐targeting agents, and establishes a genome mining‐driven platform for discovering new therapeutics against antibiotic‐resistant pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, P.R. China.
- Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, 430071, P.R. China.
ORCID-Profile: Fan Zhang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Wuhan University
Zitieren
APA
Wang, Y., Yin, J., Liao, W., Gao, Y., Yao, Y., Lu, L., Tao, W., & Zhang, F. (2025). Discovery of Antivirulence ClpP Inhibitors by Self‐Resistance Gene‐Guided Mining Coupled with Dual Functional Screening. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202514683
Vancouver
Wang Y, Yin J, Liao W, Gao Y, Yao Y, Lu L, et al. Discovery of Antivirulence ClpP Inhibitors by Self‐Resistance Gene‐Guided Mining Coupled with Dual Functional Screening. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202514683
BibTeX
@article{Wang2025,
author = {Wang, Yongchao and Yin, Jinhuan and Liao, Weiting and Gao, Yanwei and Yao, Yan and Lu, Li and Tao, Weixin and Zhang, Fan},
title = {Discovery of Antivirulence ClpP Inhibitors by Self‐Resistance Gene‐Guided Mining Coupled with Dual Functional Screening},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202514683}
}
EUVIMED